Medivir and SciLifeLab enter collaboration on potential SARS CoV-2 inhibitors
Medivir AB announced that it has entered a research collaboration with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2. Through the…
Read More...
Read More...